Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkermes is an innovative pharmaceutical company headquartered in Ireland, specializing in the research, development, and commercialization of novel medicines. The company focuses on providing groundbreaking therapies for patients with complex neurological and psychiatric diseases. Alkermes drives global healthcare forward through scientific excellence to improve quality of life.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkermes is scheduled to report its next quarterly earnings on 07/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkermes last reported quarterly earnings on 5/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.40 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.